These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
437 related items for PubMed ID: 34232492
1. Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures. Trinka E, Lattanzi S, Carpenter K, Corradetti T, Nucera B, Rinaldi F, Shankar R, Brigo F. CNS Drugs; 2021 Aug; 35(8):821-837. PubMed ID: 34232492 [Abstract] [Full Text] [Related]
2. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study. Villanueva V, Montoya J, Castillo A, Mauri-Llerda JÁ, Giner P, López-González FJ, Piera A, Villanueva-Hernández P, Bertol V, Garcia-Escrivá A, Garcia-Peñas JJ, Garamendi I, Esteve-Belloch P, Baiges-Octavio JJ, Miró J, Falip M, Garcés M, Gómez A, Gil-López FJ, Carreño M, Rodriguez-Uranga JJ, Campos D, Bonet M, Querol R, Molins A, Tortosa D, Salas-Puig J. Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784 [Abstract] [Full Text] [Related]
3. Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy. Brandt C, Wechsler RT, O'Brien TJ, Patten A, Malhotra M, Ngo LY, Steinhoff BJ. Seizure; 2020 Aug; 80():115-123. PubMed ID: 32563171 [Abstract] [Full Text] [Related]
4. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus. Strzelczyk A, Willems LM, Willig S, Rosenow F, Bauer S. Expert Rev Clin Pharmacol; 2015 Aug; 8(6):733-40. PubMed ID: 26436331 [Abstract] [Full Text] [Related]
5. Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice. Trinka E, Alsaadi T, Goji H, Maehara T, Takahashi S, Jacobs J, Renna R, Gil-López FJ, McMurray R, Sáinz-Fuertes R, Villanueva V. Epilepsia; 2023 Aug; 64(8):2094-2107. PubMed ID: 37114853 [Abstract] [Full Text] [Related]
6. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nevitt SJ, Sudell M, Tudur Smith C, Marson AG. Cochrane Database Syst Rev; 2019 Jun 24; 6(6):CD012065. PubMed ID: 31233229 [Abstract] [Full Text] [Related]
7. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nolan SJ, Marson AG, Weston J, Tudur Smith C. Cochrane Database Syst Rev; 2015 Aug 14; (8):CD001911. PubMed ID: 26275105 [Abstract] [Full Text] [Related]
8. Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study. D'Souza W, Alsaadi T, Montoya J, Carreño M, Di Bonaventura C, Mohanraj R, Yamamoto T, McMurray R, Shastri O, Villanueva V, PERMIT study group. Seizure; 2022 Aug 14; 100():56-66. PubMed ID: 35777333 [Abstract] [Full Text] [Related]
9. Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations. Nishida T, Lee SK, Wu T, Tiamkao S, Dash A. Epilepsia; 2019 Mar 14; 60 Suppl 1():47-59. PubMed ID: 30869168 [Abstract] [Full Text] [Related]
10. Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy. Rohracher A, Brigo F, Höfler J, Kalss G, Neuray C, Dobesberger J, Kuchukhidze G, Leitinger M, Trinka E. Expert Opin Pharmacother; 2016 Jul 14; 17(10):1403-11. PubMed ID: 27267634 [Abstract] [Full Text] [Related]
11. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial. French JA, Krauss GL, Wechsler RT, Wang XF, DiVentura B, Brandt C, Trinka E, O'Brien TJ, Laurenza A, Patten A, Bibbiani F. Neurology; 2015 Sep 15; 85(11):950-7. PubMed ID: 26296511 [Abstract] [Full Text] [Related]
12. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Nolan SJ, Marson AG, Weston J, Tudur Smith C. Cochrane Database Syst Rev; 2015 Jul 23; (7):CD001904. PubMed ID: 26204241 [Abstract] [Full Text] [Related]
13. PERPRISE: A prospective non-interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic-clonic seizures: First interim analysis. Steinhoff BJ, Goldmann T, Kockelmann E, Winter Y, PERPRISE Study Group. Epilepsia Open; 2024 Jun 23; 9(3):926-939. PubMed ID: 38017663 [Abstract] [Full Text] [Related]
15. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice. Alonso-Singer P, Aguilar-Amat Prior MJ, Oliva-Navarro J, Massot-Tarrús A, Giráldez BG, Bermejo P, DeToledo-Heras M, Aledo-Serrano Á, Martínez-Cayuelas E, Tirado-Requero P, Velázquez-Fragua R, López-Sobrino G, Ojeda J. Epilepsy Behav; 2022 Sep 23; 134():108836. PubMed ID: 35870432 [Abstract] [Full Text] [Related]
16. Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults. Stephen LJ, Brodie MJ. CNS Drugs; 2020 Feb 23; 34(2):147-161. PubMed ID: 31983023 [Abstract] [Full Text] [Related]
17. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures. Tyrlikova I, Brazdil M, Rektor I, Tyrlik M. Expert Rev Neurother; 2019 Jan 23; 19(1):5-16. PubMed ID: 30560703 [Abstract] [Full Text] [Related]
18. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis. Chu H, Zhang X, Shi J, Zhou Z, Yang X. J Neurol; 2023 Oct 23; 270(10):4713-4728. PubMed ID: 37378757 [Abstract] [Full Text] [Related]
19. [Optimal Use of Perampanel in the Treatment of Patients with Epilepsy Based on the Clinical Evidence and Characteristics]. Akamatsu N, Kanemoto K, Maehara T. Brain Nerve; 2022 Jul 23; 74(7):927-937. PubMed ID: 35860942 [Abstract] [Full Text] [Related]
20. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. Pediatrics; 2006 Aug 23; 118(2):e371-8. PubMed ID: 16847080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]